Ethereum’s validator exit queue fell near zero for the first time since July as staking demand increased, led by BitMine’s aggressive accumulation.
You might also be interested in reading Seres Therapeutics outlines global Phase II SER-155 trial with 248-patient enrollment amid partnership talks.